Navigation Links
LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
Date:12/25/2008

LegalView informed individuals of recent conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. The FDA has claimed that Baxter's Heparin was not the cause of death among several patients, but the agency has also alleged that that the tainted blood thinner likely did cause death among patients.

Denver, CO (PRWEB) December 25, 2008 -- LegalView.com, the number one legal resource available on the Internet, recently used its Baxter heparin information portal to report on additional controversy plaguing patients of the blood thinner. According to news reports, Rep. Joe Barton of Texas has claimed that the U.S. Food and Drug Administration (FDA) has given conflicting reports on the blood thinner, which is often given to prevent blood clots during surgical procedures including heart failure and kidney transplants, saying the drug was both responsible and not responsible for deaths of Americans. Rep. Barton has called for a Government Accountability Office (GAO) investigation into the FDA's remarks on the blood thinner.

Baxter Heparin has been at the center of a controversy this year as it was discovered that a tainted batch of heparin was given to hundreds of Americans causing allergic reactions and deaths among dozens of patients, according to news reports. The tainted heparin was eventually found to have been contaminated with a chemical known as over-sulfated chondroitin sulfate in a Chinese manufacturing plant. Not only was a heparin recall implemented, but an investigation spanning international borders was developed. A New England Journal of Medicine article from Dec. 3 claimed that the blood thinner could not have caused the deaths of several individuals, however this contradicted the FDA's previous remarks in May, which claimed that the drug was responsible for the deaths of patients, according to Dow Jones news reports.

Patients who have previously been administered the blood thinner are advised to locate an experienced Baxter heparin attorney who can offer a free legal consultation as to the development of a potential heparin class action lawsuit. Developing such litigation may offer monetary assistance to victims of the Heparin side effects and may help in paying for medical bills associated with the drug.

LegalView also offers several additional pharmaceutical practice areas on an array of topics ranging from Avandia and Byetta to the recent Chantix controversy. Both Avandia and Byetta are type 2 diabetes prescription medications, however, each drug has been in the news for different, yet severe side effects.

Avandia, from GlaxoSmithKline, uses an individual's natural insulin and regulates it in order to keep glucose on a normal and healthy level. However, the drug has been linked to severe risks including bone fractures among women, early onset osteoporosis and heart failure/damage among patients. Individuals who have suffered from the Avandia side effects are advised to contact a pharmaceutical attorney in addition to their regular medical physician.

Byetta, similar to Avandia, is a type 2 diabetes prescription medication that was released in mid-2005. In 2007, the FDA began receiving reports from Byetta patients who were suffering from pancreatitis as an unintended side effect associated with consumption of the drug. Patients who suffered from these dangers should seek legal counsel from an experienced Byetta law firm to learn more about the dangers associated with consumption of the medication.

An additional pharmaceutical prescription drug, which has sparked FDA investigations is that of Chantix, a smoking cessation drug that has been used by nearly 3 million Americans since its release in May 2006. At the end of 2007, however, hundreds of reports regarding dangerous side effects caused by the drug flooded the FDA offices. Chantix patients were allegedly developing conditions such as depression, mood disorders as well as suicidal tendencies and actions. There have allegedly been approximately 40 suicides linked to the use of Chantix, which is why it is imperative that smokers using the drug as an aid to quit smoking talk with their physician about alternative cessation methods. Additionally, it may be necessary for those individuals affected by the Chantix dangers to locate a pharmaceutical attorney for the potential development of a Chantix lawsuit.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1792594.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... Texas (PRWEB) , ... February 07, 2016 , ... ... new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information ... MyDecision™ combines three elements to cut the cost of providing employee healthcare benefits ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , ... the world with an estimated 5000 perioperative nurses in attendance to study ...
(Date:2/6/2016)... ... ... With the FCPX LUT: Summer pack from Pixel Film Studios, ... is a Lookup Table that contains a mathematical formula for modifying an image. The ... manipulating each pixel, LUT's can change each color range differently, it gives the user ...
(Date:2/6/2016)... , ... February 06, 2016 , ... ... of eating disorder treatment helps to reduce the frequency and level of relapse. ... Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its fiscal year ... --> --> GAAP results: Revenue for ... $5.1 million or 4.1% from the third quarter of ... fourth quarter of 2014. Revenue for the year ended ...
(Date:2/4/2016)... 2016  Aethlon Medical, Inc. (Nasdaq: AEMD ... to treat life-threatening diseases, today announced results for ... 31, 2015. --> ... in our last quarterly call, we strategically advanced ... objective to establish the Aethlon Hemopurifier® as a ...
(Date:2/4/2016)... 4, 2016  AMRI (NASDAQ:  AMRI) today announced that ... and President of Pfizer Global Supply, has been elected to ... 2016. In addition, the Company announced that Mr. Gabe ... since 2010, has retired from the AMRI Board of Directors ... other business ventures.  William S. Marth , ...
Breaking Medicine Technology: